Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
24.5M
-
Shares change
-
+1.22M
-
Total reported value, excl. options
-
$307M
-
Value change
-
+$19.6M
-
Put/Call ratio
-
3.21
-
Number of buys
-
44
-
Number of sells
-
-29
-
Price
-
$12.51
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q2 2017
86 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q2 2017.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.5M shares
of 31.6M outstanding shares and own 77.78% of the company stock.
Largest 10 shareholders include CADIAN CAPITAL MANAGEMENT, LP (2.26M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.21M shares), FRANKLIN RESOURCES INC (2.2M shares), FRAZIER MANAGEMENT LLC (1.89M shares), BlackRock Inc. (1.85M shares), Sectoral Asset Management Inc (1.81M shares), Rock Springs Capital Management LP (1.8M shares), TPG Group Holdings (SBS) Advisors, Inc. (1.39M shares), MACQUARIE GROUP LTD (1.12M shares), and HIGHLAND CAPITAL MANAGEMENT LP (894K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.